about
BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenet...
Read More
1.63
0.02
(1.24%)
411.5K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for BioVie Inc is on 23 Sep 2026 for the purpose of RedChip Investor Webinar
See details
Not Eligible
Expensive Valuation
Technically Neutral
BioVie Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..